Skip to content
Menu

Virtus Biotech Clinical Trials ETF BBC

Full chart Compare
Set alert

Price alert · BBC

All alert types
39.77 USD 0.00 (+0.00%)

As ofNov 19, 2026, 3:59 PM EST

39.42 Day range 40.66
33.20 52-week range 56.18
YTD
+3.14%
1 year
+17.70%

5D -2.13 (-4.93%)

4244MonWedThuFriMon41.10
YTD return
+3.14%
1-year return
+17.70%
50-day average
27.91
200-day average
27.48
Volume
154.69K
Avg volume
34.33K
Open
40.51
Previous close
39.77
Day's range
39.42 – 40.66
52-week range
33.20 – 56.18

About Virtus Biotech Clinical Trials ETF

Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.

News

No recent headlines

Headlines appear here as they are published.

Your note

Sign in to keep a note on BBC — it syncs with the Stock Master app.